PMI's IQOS and cigarette ads in Israel.

Dec.15.2022
PMI's IQOS and cigarette ads in Israel.
Philip Morris International (PMI) used legal loopholes to market smoking products to Orthodox Jewish communities in Israel.

The leading global tobacco company Philip Morris International (PMI) has taken advantage of a legal loophole in Israel's ban on advertising smoking products, targeting the extremely conservative Orthodox (Haredi) community in Israel through advertising campaigns, thus promoting smoking addiction among the residents of that region.


A new study led by Israeli doctoral student Amal Khayat and co-authored by Yael Bar-Zeev and researchers from the Braun School of Public Health and Community Medicine at Hebrew University in Israel was recently published in the academic journal "Tobacco Control". Titled "IQOS by PMI and cigarette advertising in the Israeli media: a content analysis across regulatory periods and target audience segments", the study examines the content of tobacco advertisements in Israel targeting specific groups of consumers.


Researchers analyzed marketing data from PMI to study the differences in advertising expenditures among several major population groups in Israel over the past four years, including the general population, Haredi communities, Arabic speakers, and Russian speakers.


Khayat stated, "In light of regulatory changes restricting tobacco product advertising, we have analyzed advertising expenditures for all PMI cigarette brands and IQOS brand (a heated tobacco stick introduced to the local market in December 2016).


Although restrictions on tobacco product advertising led to a significant decrease in the company's marketing expenditures, research shows that the company has been using legal loopholes in printing machines to subvert targets and maximize profits as much as possible.


Dr. Bar-Zeev explained that despite the law coming into effect, the company continued to spend nearly 3 million New Shekels on advertising, with a focus on print media. Although the law restricts print ads to one per newspaper, 40% of IQOS ads were huge double-page spreads that effectively doubled the advertising space for the product, while still being considered a single allowable ad under the law.


Another strategy utilized by PMI is to include QR codes in their advertisements, which allows readers to scan and view additional content outside of what is printed in the newspaper.


Furthermore, the advertisement shows individuals using IQOS devices to smoke in enclosed public spaces, despite laws prohibiting the use of any tobacco products in these areas. According to researchers, such ads give the impression that this behavior is legal, thereby taking advantage of the innocence of most consumers who may not be aware of these distinctions.


The study also found that prior to the enactment of this law, PMI significantly increased their advertising towards all reviewed populations, with a particular focus on the Haredi community, who had the lowest smoking rates in Israel before being targeted with PMI's marketing tactics.


According to Bar-Zeev, "Our data indicates that since introducing IQOS electronic cigarettes, 216 targeted advertisements have been released, of which 55% were created for the ultra-Orthodox community, 6% were created for the Arab public, and the rest were created for Russian-speaking audiences.


Similarly, 87% of cigarette ads are targeted towards the Haredi community, which is a surprising discovery as the company repeatedly claims to only be interested in marketing its products to existing smokers.


Bar-Zeev stated that the company is expected to focus on the population with the highest smoking rates in Israel - Arab males - rather than a population with almost no smokers.


According to research findings, Israel's 24th parliament has decided to cancel the exemption for print media advertising, but has ultimately postponed the implementation of this step for seven years. During the discussion, a series of additional restrictions were decided upon for this transition period, including the prohibition of using coupons, QR codes, and cigarette packaging that does not include mandatory plain packaging in print ads.


Bar-Zeev concluded that the restrictions were only a drop in the bucket because the study proved that tobacco companies found creative ways to continue marketing their products and addicting new generations despite the limitations. The researchers suggested that only a complete and immediate ban on all forms of advertisement, along with strict enforcement, could prevent such a scenario from happening.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
Huabao’s H1 2026 results show the company advancing across three connected fronts: international expansion, entry into next-generation tobacco supply chains and diversification beyond its traditional tobacco-related base. Overseas revenue rose 216.08% to CNY 96.02 million, while non-flavor businesses reached 42.2% of total revenue. Huabao also said it had entered the supply chains of leading global tobacco customers, as its nutrition, food ingredient, fragrance and personal-care businesses gained ground in Europe, Southeast Asia, Australia and New Zealand. However, adjusted net profit increased only 2.78%, and next-generation tobacco revenue was not separately disclosed, showing that the transformation is reshaping revenue and customer exposure but has yet to translate fully into underlying earnings.
Aug.28
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives
South Korea Fully Reviews Nicotine-Analog and Nicotine-Free Vape Liquid Imports, With Over 99% From China and Chinese Supply-Chain Documents Under Scrutiny
South Korea Fully Reviews Nicotine-Analog and Nicotine-Free Vape Liquid Imports, With Over 99% From China and Chinese Supply-Chain Documents Under Scrutiny
Korea Customs Service has tightened import controls on nicotine-analog and nicotine-free e-cigarette liquids, placing the products under 100% document review and subjecting all e-cigarette liquid import declarations to pre-clearance ingredient analysis. As of September 20, 2026, South Korea had imported about 15 metric tons of nicotine-analog liquids, 99.99% from China, and about 316 metric tons of nicotine-free liquids, including roughly 315 metric tons, or 99.7%, from China. The measures follow South Korea's April expansion of its tobacco definition to include synthetic nicotine products and include new checks on Chinese manufacturing, transaction and export documentation.
Sep.24
Retail Case Study | Wisconsin Vape Market One Year After New Regulations: Johnny Vapes Reports 80% Sales Decline as Consumers Shift Online and Across State Lines
Retail Case Study | Wisconsin Vape Market One Year After New Regulations: Johnny Vapes Reports 80% Sales Decline as Consumers Shift Online and Across State Lines
According to WNCY on August 24, 2026, some independent vape retailers in Wisconsin say they have faced significant business pressure one year after new vape regulations took effect. Johnny Vapes, a retailer operating in northeast Wisconsin, said its store count fell from seven locations to four, sales declined by about 80%, and roughly 90% of its inventory was affected. Retailers said some consumers have shifted to online purchases or traveled to neighboring Michigan to buy vape products. The case highlights how local regulations can reshape retail operations, inventory management and consumer purchasing patterns.
Aug.28
China Tobacco Yunnan files patent for cellulose-free nicotine pouch scaffold to replace microcrystalline cellulose
China Tobacco Yunnan files patent for cellulose-free nicotine pouch scaffold to replace microcrystalline cellulose
China Tobacco Yunnan Industrial Co., Ltd. has filed a patent application for a cellulose-free scaffold material for nicotine pouches, proposing a combination of bioceramic material, polydextrose and sugar alcohols to replace conventional microcrystalline cellulose and cellulose derivatives. The filing aims to address issues including powdery mouthfeel, residue and limited release control, while also reducing reliance on existing cellulose-based patent portfolios. In patent examples, one fast-release formulation reached a nicotine release rate of 50% at 10 minutes and more than 90% at 20 minutes.
Sep.02